JP2016014009A5 - - Google Patents

Download PDF

Info

Publication number
JP2016014009A5
JP2016014009A5 JP2015095225A JP2015095225A JP2016014009A5 JP 2016014009 A5 JP2016014009 A5 JP 2016014009A5 JP 2015095225 A JP2015095225 A JP 2015095225A JP 2015095225 A JP2015095225 A JP 2015095225A JP 2016014009 A5 JP2016014009 A5 JP 2016014009A5
Authority
JP
Japan
Prior art keywords
ribose
agent
subject
effective amount
per day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015095225A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016014009A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016014009A publication Critical patent/JP2016014009A/ja
Publication of JP2016014009A5 publication Critical patent/JP2016014009A5/ja
Pending legal-status Critical Current

Links

JP2015095225A 2008-08-20 2015-05-07 疲労した対象のためのd−リボースの使用 Pending JP2016014009A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18949808P 2008-08-20 2008-08-20
US61/189,498 2008-08-20
US20812209P 2009-02-20 2009-02-20
US61/208,122 2009-02-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011523814A Division JP2012500261A (ja) 2008-08-20 2009-08-20 疲労した対象のためのd−リボースの使用

Publications (2)

Publication Number Publication Date
JP2016014009A JP2016014009A (ja) 2016-01-28
JP2016014009A5 true JP2016014009A5 (2) 2016-03-10

Family

ID=41172394

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011523814A Withdrawn JP2012500261A (ja) 2008-08-20 2009-08-20 疲労した対象のためのd−リボースの使用
JP2015095225A Pending JP2016014009A (ja) 2008-08-20 2015-05-07 疲労した対象のためのd−リボースの使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011523814A Withdrawn JP2012500261A (ja) 2008-08-20 2009-08-20 疲労した対象のためのd−リボースの使用

Country Status (8)

Country Link
US (2) US20100189785A1 (2)
EP (1) EP2323668A1 (2)
JP (2) JP2012500261A (2)
CN (2) CN102215846A (2)
AU (1) AU2009283215B2 (2)
BR (1) BRPI0917360A2 (2)
CA (1) CA2734769A1 (2)
WO (1) WO2010021713A1 (2)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106138071A (zh) * 2008-04-02 2016-11-23 生物能公司 核糖在对于急性心肌梗塞的第一反应中的用途
CN102488669A (zh) * 2011-12-30 2012-06-13 上海希迪制药有限公司 一种改善d-核糖引湿性的方法
JP2017537079A (ja) * 2014-11-03 2017-12-14 バイオエナジー ライフ サイエンス,インコーポレイティド 身体的ストレスへの適応を強化するためのd−リボースの使用
WO2017120731A1 (en) * 2016-01-11 2017-07-20 Shanghai Yao Yuan Biotechnology Co., Ltd. Methods and compositions for reducing body weight
JP6542687B2 (ja) 2016-01-28 2019-07-10 日本特殊陶業株式会社 ガスセンサユニット
US10434113B2 (en) 2016-12-16 2019-10-08 The Charlotte Mecklenburg Hospital Authority Compositions and methods for treating muscular dystrophy and other disorders
US20190313682A1 (en) * 2018-04-12 2019-10-17 Metabolic Recovery Systems, LLC Compositions and methods for supplementing the diet
US20200061092A1 (en) * 2018-08-24 2020-02-27 The Charlotte Mecklenburg Hospital Authority D/B/A Atrium Health Methods and compositions for treating disorders associated with muscle weakness
KR102435548B1 (ko) * 2022-05-31 2022-08-26 (주)에이피테크놀로지 액상스틱형 에너지 스포츠 음료

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4228215A1 (de) * 1992-08-25 1994-03-03 Pliml Wolfgang Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
EP1745789A1 (en) * 1998-06-19 2007-01-24 Bioenergy Inc. Compositions comprising ribose for increasing energy in vivo
US6159943A (en) * 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
GB2353217B (en) * 1999-10-27 2001-07-18 Bioenergy Inc Use of ribose to treat fibromyalgia
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
IT1317043B1 (it) * 2000-06-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio.
US6855727B2 (en) * 2000-12-04 2005-02-15 Yaizu Suisankagaku Industry Co., Ltd. Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
JP4754484B2 (ja) * 2004-03-18 2011-08-24 田辺三菱製薬株式会社 うつ様症状改善剤
US20050277598A1 (en) * 2004-04-29 2005-12-15 Maccarter Dean J Method for improving ventilatory efficiency
US20100099630A1 (en) * 2004-04-29 2010-04-22 Maccarter Dean J Method for improving ventilatory efficiency
US7645742B2 (en) * 2005-06-22 2010-01-12 Advocare International, L.P. Composition for enhancing cellular energy
JPWO2022123637A1 (2) 2020-12-07 2022-06-16

Similar Documents

Publication Publication Date Title
JP2016014009A5 (2)
IL285107A (en) Diagnostic, prognostic and therapeutic uses of long non-coding RNA molecules for heart diseases and rehabilitation medicine
PL3439660T3 (pl) Stosowanie pimobendanu w celu redukowaniu wielkości serca i opóźnienia początku objawów klinicznych u pacjentów z bezobjawową niewydolnością serca w wyniku choroby zastawki mitralnej
JP2016515522A5 (2)
JP2014507482A5 (2)
MA34019B1 (fr) Aryltriazolone liée à un bis-aryle et son utilisation
LT3730132T (lt) Kompozicija, skirta panaudoti pacientų su didele širdies ir kraujagyslių ligų rizika antsvorio ir nutukimo gydymo būde
JP2016519107A5 (2)
JP2015535291A5 (2)
BR112016007238A2 (pt) tienouracilcarboxamidas cíclicas e sua utilização
Relf et al. Essential nursing competencies related to HIV and AIDS
JP2019528267A5 (2)
JP2017061488A5 (2)
Hagen et al. Emerging adverse cutaneous drug reactions
Goel Emergency care for older people in India
Dhakal Indigenous Knowledge and Global Wellness
WO2014011273A3 (en) Pro-inflammatory mediators in diagnosis and treatment of pulmonary disease
Senatorova et al. MODERN PRINCIPLES OF DIAGNOSTICS AND ТАCTICS OF CARE NEWBORNS WITH CONGENITAL HEART DISEASES
McDaniel et al. The self of the medical family therapist.
IT201700048039A1 (it) Letto ideato per effettuare gli esercizi di “Training for Good Sleeping” e migliorare la qualità del sonno e della vita.
Isitan Encephalopathy: case report
Chai-Coetzer et al. A randomised controlled trial comparing patient outcomes following full polysomnography versus limited sleep study testing for suspected obstructive sleep apnea
Kaleth et al. To evaluate the relationship between long-term maintenance of moderate to vigorous physical activity (MVPA) and clinical outcomes in fibromyalgia (FM).
Jongstra eHealth in cardiovascular risk management to prevent cognitive decline
CN301978866S (zh) 低频率治疗器